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Abstract
Background. Musculoskeletal problems are common reasons for seeking primary health care. 
It has been suggested that many people with ‘everyday’ non-inflammatory musculoskeletal 
problems may have undiagnosed joint hypermobility syndrome (JHS), a complex multi-systemic 
condition. JHS is characterized by joint laxity, pain, fatigue and a wide range of other symptoms. 
Physiotherapy is usually the preferred treatment option for JHS, although diagnosis can be difficult. 
The lived experience of those with JHS requires investigation.
Objective. The aim of the study was to examine patients’ lived experience of JHS, their views and 
experiences of JHS diagnosis and management.
Methods. Focus groups in four locations in the UK were convened, involving 25 participants 
with a prior diagnosis of JHS. The focus groups were audio recorded, fully transcribed and 
analysed using the constant comparative method to inductively derive a thematic account of 
the data.
Results. Pain, fatigue, proprioception difficulties and repeated cycles of injury were among the 
most challenging features of living with JHS. Participants perceived a lack of awareness of JHS 
from health professionals and more widely in society and described how diagnosis and access to 
appropriate health-care services was often slow and convoluted. Education for patients and health 
professionals was considered to be essential.
Conclusions. Timely diagnosis, raising awareness and access to health professionals who 
understand JHS may be particularly instrumental in helping to ameliorate symptoms and help 
patients to self-manage their condition. Physiotherapists and other health professionals should 
receive training to provide biopsychosocial support for people with this condition.
Key words: Benign hypermobility syndrome, diagnosis, Ehlers–Danlos syndrome, hypermobility type, life experiences, referral, 
self-management.
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Introduction
Musculoskeletal problems are common reasons for seeking primary 
health care (1). Joint hypermobility syndrome (JHS) is a hereditary 
connective tissue disorder, characterized by musculoskeletal pain 
and an excessive range of motion in joints (2). As there are no labo-
ratory tests to indicate JHS (3), it is usually subjectively assessed 
using the Brighton criteria (4), which include the Beighton score (5) 
for joint hypermobility. It has been reported that symptomatic joint 
hypermobility affects around 5% of women and 0.6% of men (6). 
The prevalence of JHS amongst those attending rheumatology and 
physiotherapy clinics has been estimated to be between 30% and 
60% and is higher in non-Caucasian populations (7,8). However, 
the diverse and fluctuating symptoms associated with JHS may easily 
be attributed to other causes and the true prevalence of JHS may be 
much higher than previously estimated. It has been suggested that 
many patients presenting with painful non-inflammatory musculo-
skeletal problems may have unrecognized JHS (9).
Although most individuals exhibiting joint hypermobility do not 
experience problems, a diagnosis of JHS may be given when symptoms 
such as arthralgia, proprioception difficulties, fatigue, soft tissue injury 
and joint instability are observed in the absence of genetic markers to 
indicate disorders such as osteogenesis imperfecta or Marfan syndrome 
(10). JHS, osteogenesis imperfecta, Marfan syndrome and Ehlers–
Danlos syndrome share many symptoms and many experts now 
consider JHS to be indistinguishable from Ehlers–Danlos syndrome, 
hypermobility type (11). In this article, the term JHS will be used.
Primary-care practitioners are usually the patients’ first point 
of contact on entering the health-care system. They can do much 
to assist individuals to effectively self-manage their condition (12) 
and refer patients for appropriate secondary care such as physio-
therapy, although the effectiveness of physiotherapy has yet to be 
established due to the lack of high-quality research in this area (13). 
The lived experience of JHS from patients’ perspectives has received 
little attention. The aim of the current investigation is to examine 
patients’ lived experience of JHS, their views and experiences of JHS 
diagnosis and management.
Methods
Four focus groups were conducted between January and February 
2013 in four locations in the UK. Participants were recruited via 
physiotherapy services at two National Health Service (NHS) 
trusts, local members of the Hypermobility Syndromes Association 
(HMSA) and patients who had previously expressed an interest in 
assisting with research activity at two University locations. Eligible 
participants were aged 18 years or over, had previously received a 
diagnosis of JHS (including Ehlers–Danlos syndrome, hypermobility 
type), had attended physiotherapy within the preceding 12 months 
and were able to speak English.
Individuals with other known musculoskeletal pathology causing 
pain, particularly osteoarthritis and inflammatory musculoskeletal 
disease such as rheumatoid arthritis, were excluded. The purpo-
sive sampling strategy aimed for diversity with regard to age, gen-
der, socio-economic situation and geographical location to capture 
maximum variation in views and experiences. Ethical approval was 
obtained from the North East NHS Research Ethics Committee (12/
NE/0307) and all participants gave written consent.
Procedure
Data reported in this article were collected from focus groups 
with individuals with JHS, aimed at developing a physiotherapy 
intervention for JHS management. Topic guides used to facilitate 
discussions covered issues of living with JHS, day-to-day self-man-
agement and provision of support for symptom management. In line 
with an inductive approach, topic guides were revised in the light of 
emerging findings. The focus groups were conducted in non-clinical 
settings, facilitated by two researchers (STP and JPH), and open-
ended questioning techniques were used to elicit participants’ own 
experiences and views. The focus groups lasted between 71 and 100 
minutes.
Data analysis
All focus groups were audio-recorded, fully transcribed, anonymized, 
checked for accuracy and imported into a qualitative software pack-
age (NVivo 10)  to aid data analysis. Thematic analysis, using the 
constant comparison technique (14), was used to scrutinize the data 
to identify and analyse patterns across the dataset and the data were 
scrutinized for negative cases. Transcripts were examined on a line-
by-line basis, with codes being assigned to segments of the data and 
an initial coding frame developed. An inductive approach was used 
to identify participants’ perceptions of their experiences. RHT and 
JPH independently coded transcripts and any discrepancies were 
discussed to achieve a coding consensus and maximize rigour. The 
emergent themes were discussed by the multi-disciplinary research 
team to ensure credibility and confirmability. Scrutiny of the data 
showed that data saturation had been reached at the end of the 
analysis, such that no new themes were arising from the data (15).
Results
Twenty-five individuals with JHS participated in the focus groups, 
aged 19–66 years (mean: 38.2 years), 22 were female and 23 were 
of ‘White’ ethnicity (Table 1). The analysis led to the development of 
four key interrelated themes: ‘the impact of JHS’, ‘JHS as a poorly 
understood condition’, ‘receiving a diagnosis’ and ‘JHS manage-
ment and self-care’. Verbatim extracts are provided to illustrate the 
findings.
The impact of JHS
Participants described in detail the impact of JHS, which included 
fatigue, pain and proprioception problems:
…day in day out you’re managing your pain and it’s a lot of pain, 
it’s a dull ache and it makes you sleepy and it makes you tired and 
you’re exhausted (Female G, age 30, FG1).
…it’s on your mind the whole time because I’m constantly 
thinking about where my hands and feet are (Female G, age 48, 
FG2).
Recurring joint dislocation and ‘cycles’ of injury and recovery were 
common and participants frequently talked about the need to mod-
ify or restrict behaviours and activities.
...it’s just difficult to know how much to push yourself because 
then you are worried about injuring and then you’re setting your-
self back, it’s a vicious cycle really (Female B, age 27, FG3).
However, participants acknowledged that the impact and conse-
quences of these varied symptoms were different for each patient, 
with one participant noting, ‘all of us are probably so different yet 
we’re categorised as the same’ (Female D, age 21, FG1). Thus, some 
participants found living with JHS symptoms to be ‘very debilitat-
ing’, (Male E, age 36, FG3), whilst others were determined to perse-
vere with their chosen activities, in spite of their symptoms:
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I teach like rock-climbing, surfing, body boarding and all of that 
stuff, like, and I’m not going to stop doing it because I’m in pain 
like you can’t live your whole life with pain dictating what you 
can and can’t do (Female G, age 45, FG3).
Although JHS is characterized by pain, participants alluded to the 
complexity of their pain experience, for example, describing difficul-
ties in distinguishing between chronic and acute pain, and in recog-
nizing how—or ‘if’—injuries had occurred:
how do we know whether we’ve injured something? Because 
we’ve got pain all the time (Female C, age 40, FG1).
Participants also described how prior experiences of repeated inju-
ries led to heightened levels of anxiety and catastrophizing about 
future injuries: ‘I feel like I’m in a constant state of anxiety, waiting 
for the next injury and trying to pre-empt anything that’s going to 
cause it’ (Female G, age 48, FG2). Others extrapolated their current 
or prior experiences to an imagined future: ‘Oh my god is this going 
to be like this for the next 60 years of my life?’ (Female B, age 27, 
FG3).
‘JHS—a poorly understood condition’
Participants perceived JHS to be a condition that was poorly under-
stood by health professionals, and within society more widely.
I think I was described as a biomechanical conundrum by one of 
the physiotherapists I saw […] and this is what I found repeated 
over and over again, that hypermobility shouldn’t be causing 
pain, it’s just the way you are’ (Female C, age 53, FG2).
Participants described feeling stigmatized and fraudulent:
…I’m really struggling, but because of people’s expectations and 
their perceptions and you don’t want to ruin that, you don’t want 
people to start thinking “oh well, you know, [unclear 1.02.47], 
we don’t employ people with disabilities because this is what hap-
pens” (Female C, age 40, FG1).
They think you’re trying to cheat out of doing something … 
(Female D, age 21, FG1).
and felt they had been ‘blamed’ for their symptoms:
when I was at school I just had to sit at the side while they were 
doing all the games, they sort of almost, I felt they were blaming 
it on me … (Female D, age 32, FG3).
Participants reported how they felt they were ‘the odd one out’ 
(Female B, age 34, FG2) and tried to hide their experiences and 
appear ‘normal’:
‘… it’s so exhausting mentally and physically to try and appear to 
be normal and do normal things throughout the day with every-
body and pretend it’s alright’ (Female G, age 48, FG2).
Participants felt that the unpredictable, diverse, evolving and fluctu-
ating nature of their symptoms exacerbated others’ misunderstand-
ing of the nature of JHS and contributed to a lack of social support:
if you’re inconsistent as well, they sort of go, ‘she was alright with 
that last week, why is it this week she’s saying that, you know, 
that’s going to be difficult for her today’ (Female C, age 53, FG2).
Receiving a diagnosis
Many participants reported lengthy diagnosis trajectories, and being 
treated for individual symptoms (e.g. pain) rather than JHS:
we’ve all been passed from pillar to post where people don’t rec-
ognise it or they just attribute a pain to something else, when a 
snap kind of diagnosis just comes out of the air and you know, 
you progress from there (Female G, age 45, FG3).
Often, obtaining a correct diagnosis was a coincidental occurrence:
it was only because a locum happened to be in the day I went in 
because my GP was off sick, and he just started saying, well, to start 
bending everything… but if hadn’t been for him I wouldn’t have been 
put on the right track, … because otherwise what other route do you 
really have if it’s not through your GP? (Female B, age 27, FG3).
Receiving a diagnosis was considered necessary in order to access 
appropriate care pathways, for example, referral for physiotherapy 
for JHS rather than for an acute single joint problem:
I was originally seen by a physio who hadn’t diagnosed with the 
hypermobility and then went back to a musculo-skeletal special-
ist who then put me forward to specialist hypermobility physi-
otherapist and since then it’s been amazing; I  feel like it’s been 
worthwhile and it felt like the right thing to do and I’ve been 
really enjoying it (Female B, age 27, FG3).
In addition, a diagnosis helped to validate participants’ experiences 
and was psychologically helpful:
Getting a diagnosis on paper, this is what’s wrong with me? 
I mean that helped me hugely psychologically (Female A, age 60, 
FG2).
Table 1. Participants’ characteristics and demographic information 
relating to the participants of the four focus groups, carried out 
between January and February 2013 (total n = 25)
Characteristic Subcategory n (except where 
specified)
Age (years) 18–29 8
30–39 7
40–49 6
50–59 2
>60 3
– Mean 38.2,  
median 36 years
Gender Female 22
Male 3
Ethnicity White 23
Other 2 (both ‘British 
White and Chinese’)
Socio-economic 
status (SES)a
1 (least deprived) 8
2 8
3 4
4 3
5 (most deprived) 1
Education Left school 
<16 years/schooling 
to 16 years
3
College diploma  
or equivalent
6
University degree  
or equivalent
10
Postgraduate degree 6
Employment Employed full time 7
Employed part time 8
Student full time 4
No paid job 5
Retired 1
aSES was measured as Index of Multiple Deprivation (IMD) quintile from 
home postcode.
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A diagnosis in itself, however, still did not guarantee beneficial 
treatment:
When I was first diagnosed, I wasn’t, I really felt I wasn’t given 
that much information about the condition […] and it just seemed 
to be all exercises they’d given me at the time seemed to make me 
worse (Female B, age 27, FG3).
Similarly, a diagnosis did not necessarily lead to greater understand-
ing and support from others in the participants’ social networks:
There are people who don’t feel it’s a genuine diagnosis, that it’s 
something psychological, that you just need to be a bit braver 
(Female A, age 21, FG2).
‘JHS management and self-care’
Education
Education for health professionals was a key issue for participants, 
to facilitate timely diagnosis of, and referral for, JHS. Thus, educa-
tion for health professionals was a prerequisite for diagnosis, and 
diagnosis was a prerequisite for participants to access education. 
Participants recognized that individuals with JHS also need educa-
tion, in order to find ways to self-manage their condition and to 
understand and engage with prescribed treatments.
I suppose it’s where someone who doesn’t really know about it, 
they’ve got to learn about it first because you can’t tell someone 
to do it [ie engage with a particular treatment] if they don’t under-
stand it (Female D, age 21, FG1).
Participants also felt that they could provide valuable information 
about the nature of JHS to clinicians:
I think actually it’s the health professionals that need educating 
[….] there’s lots of things I still need to know about hypermobil-
ity, but on the flip side I do think it’s the health professionals that 
need to know more (Female G, age 42, FG3).
Participants described learning and understanding about JHS as a 
two-way process:
So I  think I get a huge amount of enlightenment from her [the 
physiotherapist], and I  lend her books and she lends me books 
about hypermobility and all that helps (Female D, age 54, FG2).
Identifying specific self-care activities
Participants accepted that treatment should aim to manage symptoms 
rather than provide a cure: ‘it’s all about them helping you to man-
age your pain, rather than cure it’ (Female, age 44, FG1). Participants 
recognized the importance of self-care activities such as appropriate 
exercise, once a diagnosis had been received and a clear understanding 
of JHS had been developed. Participants also recognised that activ-
ity pacing ‘is really key’ to managing JHS symptoms (Female B, aged 
32): ‘I have this balancing act, if I do too much it all hurts, don’t do 
enough, it all hurts, do it just right, I’m okay’ (Male A, age 50, FG1).
Participants sought to deepen their understanding of JHS and 
access to health professionals who understood the nature of JHS in 
order to take a ‘whole-body’ approach to self-care over a life course:
the more you see the physio who knows what they’re talking 
about … the more you understand how the body works and the 
more you can apply your own sort of thinking to what you’re 
doing in your exercises (Female E, age 44, FG1).
Yeah, it’s got to be holistic, it really has to be (Female D, age 
21, FG1).
Participants also felt that education about JHS should be provided at 
an early age, and therefore, early diagnosis was necessary:
I’m only 19 now but if you’d have said that when I  was 16, 
I might not be in as much pain as I am now […] so if like if they’d 
have told me more about how to treat it back then it probably 
wouldn’t be as bad as it is now (Female F, age 19, FG3).
Discussion and conclusions
Participants provided many insights into the lived experience of JHS. 
Pain, fatigue and repeated episodes of injury were particularly chal-
lenging features of the wide-ranging symptoms of JHS. Bury (16) 
describes how chronic illness brings about ‘biographical disruption’, 
and that the illness or disease requires the individual to make cer-
tain changes to their lives (17,18). In our study, participants’ lives 
were disrupted repeatedly by fluctuating symptoms and ‘cycles’ of 
injury and recovery. Participants described the complex and indi-
vidual nature of their pain experience and their responses to unpre-
dictable symptoms. For some, previous episodes of pain or injury 
led to heightened levels of anxiety and catastrophizing about the 
future and their symptoms required them to modify or restrict their 
activities, while others refused to be ‘dictated to’ by their symptoms.
Participants also explained the psychosocial consequences of liv-
ing with JHS. Patients perceived JHS to be often poorly understood 
by health professionals and those in their wider social environment 
and reported feeling fraudulent and blamed for their symptoms. 
Participants felt stigmatized, ‘marked out as different (19)’ and 
‘alien’ to others in society and found it exhausting to try to ‘appear 
normal’. Stigma can have wide-ranging negative biopsychosocial 
consequences including reduced participation in activities and an 
exacerbation of disability and disease, for example, through delayed 
diagnosis and treatment (20).
A lack of awareness of JHS amongst health professionals meant 
that obtaining a diagnosis of JHS was often difficult. Participants 
had often been misdiagnosed or treated for symptoms (e.g. pain) 
rather than the condition itself and ‘passed from pillar to post’ often 
until a serendipitous or coincidental diagnosis of JHS was made. 
Previous studies have reported similar findings (9) and others have 
emphasized that being understood and believed by health profes-
sionals and significant others, along with social support, is instru-
mental in long-term pain management by facilitating (or inhibiting) 
pain acceptance (21,22). Participants highlighted the importance of 
a correct diagnosis in facilitating access to appropriate health care, 
support and education and helping to validate participants’ experi-
ences. Having lived with problematic symptoms of JHS sometimes 
for long periods of time, it is possible that the receipt of a diagnosis 
represented the beginning of a process during which they were able 
to understand and make sense of their symptoms, obtain appropri-
ate treatment and subsequently find ways to self-manage the condi-
tion. Participants’ experiences resonate with Williams (23) who uses 
the term ‘narrative re-construction’ to describe how individuals with 
chronic illness re-establish order and meaning in their lives.
Primary-care practitioners play an important role in helping 
patients to understand and self-manage long-term health conditions. 
A prerequisite of being able to provide support for patients is that pri-
mary-care practitioners are able to recognize and diagnose JHS and 
to refer patients to JHS-trained specialists. Without a correct diagno-
sis, unsuitable treatments or information may be given, which may 
exacerbate symptoms (24). Currently, primary-care practitioners and 
other health professionals such as physiotherapists do not routinely 
receive training related to JHS (9) and the validity of diagnostic cri-
teria (such as the Beighton score) has recently been questioned (25).
Education and access to information was important for par-
ticipants to allow them to make informed health-care choices. 
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Participants described the value of collaborating with health profes-
sionals and reciprocal learning between practitioners and patients 
in order to develop effective self-care strategies, and for holistic 
long-term management. Recognizing that JHS would not be cured, 
participants felt that health professionals and those with JHS could 
potentially develop a deeper understanding of JHS management by 
learning from each other as a ‘teachable dyad (26, p. 682)’.
Strengths and limitations
To ensure validity, participants were recruited from four different 
geographical locations in the UK and had the experience of different 
health-care services. Participants provided rich personal narratives of 
the day-to-day experiences of living with and managing JHS from 
patients’ perspectives and data analysis demonstrated general con-
sensus and shared experiences. A  limitation of this research is that 
participants were recruited through JHS support groups or via physi-
otherapy services for JHS and may therefore have been more ‘active’ 
or ‘aware’ of their condition than, for example, newly diagnosed indi-
viduals. The focus groups formed one phase of a study to develop a 
physiotherapy intervention to manage JHS. It was clear that the lived 
experience of those with JHS that emerged from the data analysis 
was an important ‘story’, which to date has received little attention. 
The issues raised in these focus groups highlight the need for more in-
depth research in this area. Future research could conduct interviews 
to provide a more detailed investigation of personal accounts of liv-
ing with JHS, in particular those newly diagnosed with JHS.
Implications for practice
Individuals with JHS experience diverse, fluctuating and often debilitat-
ing symptoms and diagnosis is often slow. Without a correct diagnosis, 
treatment may exacerbate symptoms. Increased awareness of JHS in 
primary care could help improve the diagnosis and referral processes. 
Following diagnosis, access to JHS-trained health professionals could 
help patients to effectively manage their condition over a life course 
and receive psychological support when needed. Patients and practi-
tioners may be able to learn from one another and so assist in develop-
ing a deeper understanding of a currently poorly understood condition.
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